# 3wVentures

> 3wVentures is a VC fund in Herisau backing Software and Health Care. See 42 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Herisau, Switzerland
- Total investments: 42
- Last investment: Mar 2018
- Lead investor: 2%
- Fund size: $100M
- Last fund: Dec 1999
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/3wventures/
- X (Twitter): http://twitter.com/3wVentures
- Website: http://www.3wventures.com

3wVentures is a VC fund in Herisau focused on Software and Health Care. 3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.

## Contacts

5 contacts available for 3wVentures. Shizune tracks 2 team members at 3wVentures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/3wventures-com?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $50k–$3.8M |
| Angel | $583k–$2.1M |
| Series A | $1.2M–$8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 11 | 26% |
| Health Care | 7 | 17% |
| Medical | 5 | 12% |
| Search Engine | 5 | 12% |
| Information Technology | 5 | 12% |

86 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 20 | 48% |
| Angel | 11 | 26% |
| Series A | 8 | 19% |
| Series B | 1 | 2% |
| Series C | 1 | 2% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 34 | 81% |
| Spain | 1 | 2% |
| Austria | 1 | 2% |
| Germany | 1 | 2% |
| United States | 1 | 2% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Arvin Zuberbuehler | Co-Founding Partner | 2 | https://shizune.co/investors/profile/arvin-zuberbuehler |
| Yves Latour | Co-Founder | 4 | https://shizune.co/investors/profile/yves-latour |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Abionic | Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from: |  | Series C | Mar 28, 2018 |  |
| Pregnolia | Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management. | $3.8M | Seed | Feb 14, 2018 |  |
| GUURU Solutions | GUURU is a Customer Interaction Solution that combines AI with the human experience of product users. We enable brands to provide efficient First Contact Resolution with a single platform leveraging their most proficient and dedicated customers. Contact us to find out more. | $933K | Seed | Jan 26, 2018 |  |
| Picstars AG | PICSTARS was founded in 2014 and is one of the top 10 tech startups in Switzerland (Venture Leader 2016). Their mission is to digitize the sponsorship of brand ambassadors with a focus on athletes. With PICSTARS, Brands find suitable talents in Sport & Lifestyle as brand ambassadors who use their own social media channels to communicate brandphoto / video and hashtag campaigns. In the PICSTARS cockpit, companies can create campaigns directly and measure success. | $2.3M | Series A | Jan 23, 2018 |  |
| Insolight | Insolight is an energy company that develops and manufactures solar panels. Insolight has developed solar modules with record efficiency 29 percent to reduce residential solar electricity costs below 0.1 $/kWh. Its innovative optical technology combines high efficiency with the ease of mounting of a standard flat panel. Insolight hassuccessfully passed third-party validation at Fraunhofer ISE (36% efficiency on Lab prototype) and at the UPM in Madrid (29% on pre-industrial module). Its business model is to develop the IP, control wholesale distribution and outsource manufacturing.The company was founded in 2015. | $2.7M | Seed | Jan 22, 2018 |  |
| Firstbird | Firstbird, the digital employee referral program, connects people with jobs and companies worldwide with suitable candidates. With Firstbird, employees become brand ambassadors, and referrals become a company’s most successful recruiting channel. Firstbird integrates easily with your ATS to make your life easier. | $2.2M | Seed | Jan 16, 2018 |  |
| BYHOURS | BYHOURS is the first online hotel booking platform and app that allows you to book microstays in hotels in sets of 3, 6, and 12 hours and let’s you decide the time of arrival and departure. BYHOURS has introduced a new and disruptive business model in travel industry, about micro-stays and pay-per-use and based in flexibility, which also allowhotels to increase their income, as well as monetize and optimize their resources. Founded in March of 2012 in Barcelona, the company has experienced rapid growth, and does business with more than 2500 hotels in Europe, Latin America and some key cities in Middle East, and works in partneship with the international top hotel chains. | $3.3M | Series A | Dec 15, 2017 |  |
| Astrocast | Astrocast SA is the most advanced SatIoT Service for customers looking to track, monitor, manage, and communicate with assets in remote regions of the world. With the world's most innovative nanostatelliite network, Astrocast delivers a complete end-to-end, direct-to-orbit service that, state-of-the-art communication modules, and enterpriseclass services. In partnership with Airbus, CEA/LETI, the European Space Agency, and Thuraya, Astrocast has developed Astronode S, a cutting-edge terminal featuring low profile L-band antenna, ultra-low power consumption, and a small form factor. Astrocast enables companies like Marine Instruments and Wildlife Computers to expand their IoT strategies. | $4.8M | Seed | Aug 25, 2017 |  |
| DBS System | DBS System SA, producer of HemaXis™ blood collection devices, is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes.They produce devices with patented microfluidic technology capableof plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis.DBS System is “Unleashing Labs to Stay Well”. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well.HemaXis will help democratize blood collection and support “big data” initiatives important to the development of effective and efficient personalized medicine. | $2.9M | Series A | May 04, 2017 |  |
| Beekeeper | Beekeeper is a mobile-first communication platform that reaches every shift, location, and language through real-time messaging and targeted streams. Managers keep frontline teams productive and turnover low by automating workflows while leveraging an analytics dashboard to measure engagement. Beekeeper integrates with operational systems, makingthem accessible in one central portal. | $8M | Series A | Mar 21, 2017 |  |

10 of 42 investments shown.

## Co-investors
- [Verve Ventures](https://shizune.co/investors/profile/verve-ventures) — VC Fund, 28 deals together
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund, 8 deals together
- [Business Angels Switzerland (BAS)](https://shizune.co/investors/profile/business-angels-switzerland-bas) — VC Fund, 4 deals together
- [GoBeyond](https://shizune.co/investors/profile/go-beyond) — VC Fund, 3 deals together
- [Swisscom Ventures](https://shizune.co/investors/profile/swisscom-ventures) — VC Fund, 3 deals together
- [Airbus Ventures](https://shizune.co/investors/profile/airbus-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [All Investors in Switzerland](https://shizune.co/investors/investors-switzerland)
- [All VC Funds in Switzerland](https://shizune.co/investors/vc-funds-switzerland)
- [SaaS Investors in Switzerland](https://shizune.co/investors/saas-investors-switzerland)
- [SaaS VC Funds in Switzerland](https://shizune.co/investors/saas-vc-funds-switzerland)
- [Enterprise VC Funds in Switzerland](https://shizune.co/investors/enterprise-vc-funds-switzerland)
- [Software Investors in Switzerland](https://shizune.co/investors/software-investors-switzerland)

## FAQ

### What does 3wVentures invest in?

3wVentures invests primarily in Software, Health Care and Medical startups, most often at Seed and Angel stage. Most of the 42 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is 3wVentures's check size?

3wVentures typically joins rounds of $50k–$3.8M at Seed, $583k–$2.1M at Angel and $1.2M–$8M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds 3wVentures participates in.

### How do I contact 3wVentures?

Public channels for 3wVentures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at 3wVentures?

The team at 3wVentures includes Arvin Zuberbuehler (Co-Founding Partner) and Yves Latour (Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co